Patent details

EP2853257 Title: Pharmaceutical formulations of linagliptin

Basic Information

Publication number:
EP2853257
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP141844621
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutical formulations of linagliptin
French Title of Invention:
Formulations pharmaceutiques de linagliptine
German Title of Invention:
Pharmazeutische Formulierungen von Linagliptin
SPC Number:

Dates

Filing date:
11/09/2014
Grant date:
02/11/2022
EP Publication Date:
01/04/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/11/2022
EP B1 Publication Date:
02/11/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/09/2023
Expiration date:
11/09/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/10/2022
 
 

Name:
Sanovel Ilac Sanayi ve Ticaret A.S.
Address:
Balabandere Cad. Ilac Sanayi Yolu No: 14 Istinye, 34460 Istanbul, Türkiye (TR)

Inventor

1

Name:
Türkyilmaz, Ali
Address:
Türkiye (TR)

2

Name:
Turp, Ali Hasan
Address:
Türkiye (TR)

3

Name:
Saydam, Mehtap
Address:
Türkiye (TR)

Priority

Priority Number:
201310724
Priority Date:
12/09/2013
Priority Country:
Türkiye (TR)

Classification

IPC classification:
A61K 9/00; A61K 9/20; A61K 31/522; A61P 3/10;

Publication

European Patent Bulletin

Issue number:
202244
Publication date:
02/11/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages